BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Policy

  Kyros Law Announces that it is Filing Legal Claims on Behalf of Valeant Pharmaceuticals Intl Investors

  Kyros Law Offices is alerting investors of Valeant that it is filling legal claims against the company for possible securities fraud violations committed by Valeant Pharmaceuticals Intl

  May 15, 2018

   · 

  2 min read
• Biotech Beach

  Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners

  Investment will enable Surface to fund its development programs focused on FDA approval of its ocular disease drug candidates

  May 15, 2018

   · 

  6 min read
• Business

  Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018

  Palatin is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential

  May 15, 2018

   · 

  17 min read
• Neovasc’s Management and Board of Directors Urge Shareholders to Vote In Favor of the Proposed Reverse Stock Split at the Upcoming Annual General and Special Meeting of Shareholders

  Neovasc Inc. is a leader in the development of minimally invasive transcatheter mitral valve replacement technologies

  May 15, 2018

   · 

  13 min read
• Business

  Motus GI Reports 2018 First Quarter Financial Results and Provides Business Update

  Q1 2018 marked by significant corporate and clinical advancements, including successfully completing $17.5M IPO and listing on NASDAQ Capital Marke

  May 15, 2018

   · 

  9 min read
• Pharm Country

  PAVmed Announces Adjustment to Series Z Warrant Exercise Price

  The effective date of the exercise price reduction will be June 1, 2018.

  May 15, 2018

   · 

  3 min read
• Business

  Aquinnah Pharmaceuticals Appoints Travis Wager as Vice President of Research

  Former Pfizer research lead to drive development of Aquinnah’s neurodegenerative therapeutic development programs

  May 15, 2018

   · 

  3 min read
• Business

  Accelerator Life Science Partners Broadens its Leadership Teams and Expands its Geographic Operations to San Diego and the Greater Los Angeles Area

  Newly formed Operating Partners group and Clinical and Scientific Advisory Board to provide critical insights to support portfolio companies’ success and guide investment strategies

  May 15, 2018

   · 

  3 min read
• Biotech Beach

  Laguna Diagnostics Announces Publication of Peer-Reviewed Study in Molecular Neuropsychiatry

  Study developed potential blood-based biomarkers for differential diagnosis of schizophrenia and bipolar disorder

  May 15, 2018

   · 

  3 min read
• Business

  TraceLink Achieves 69% Overall Revenue Growth in Q1 2018, Including 270% Revenue Growth in EMEA

  TraceLink is the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes

  May 15, 2018

   · 

  5 min read